|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1611-1617
GENE THERAPY
Adenovirus-mediated expression of a mutant I B kinase 2 inhibits the response of endothelial cells to inflammatory
stimuli
Wolfgang Oitzinger,
Renate Hofer-Warbinek,
Johannes A. Schmid,
Yuri Koshelnick,
Bernd R. Binder, and
Rainer de Martin
From the Department of Vascular Biology and Thrombosis
Research, University of Vienna, Vienna, Austria.
In a variety of cell types, the transcription factor nuclear factor
B (NF- B) functions as a mediator of stress and immune responses.
In endothelial cells (ECs), it controls the expression of genes
encoding, eg, cytokines, cell adhesion molecules, and procoagulatory
proteins. This study investigates the effect of NF- B suppression on
several pathophysiologic functions of ECs, including inflammation,
coagulation, and angiogenesis. A recombinant adenovirus was generated
for expression of a dominant negative (dn) mutant of I B
kinase 2 (IKK2), a kinase that acts as an upstream activator of
NF- B. dnIKK2 inhibited NF- B, resulting in strongly reduced
nuclear translocation and DNA binding activity of the transcription
factor and lack of expression of several proinflammatory markers,
including E-selectin, intercellular adhesion molecule 1, vascular cell
adhesion molecule 1, and interleukin-8. Concomitantly, inhibition of
leukocyte binding to dnIKK2-expressing ECs could be demonstrated in a
cell adhesion assay. Furthermore, expression of tissue factor as well
as the ability to form capillary tubes in a matrigel assay was impaired
in dnIKK2-expressing ECs. These data demonstrate that NF- B is of
central importance not only for the inflammatory response but also for
a number of other EC functions. Therefore, this transcription factor as
well as its upstream regulatory signaling molecules may represent
favorable targets for therapeutic interference.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Chavey, M. Muhlbauer, C. Bossard, A. Freund, S. Durand, C. Jorgensen, C. Jobin, and G. Lazennec
Interleukin-8 Expression Is Regulated by Histone Deacetylases through the Nuclear Factor-{kappa}B Pathway in Breast Cancer
Mol. Pharmacol.,
November 1, 2008;
74(5):
1359 - 1366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Stuhlmeier
Hyaluronan Production in Synoviocytes as a Consequence of Viral Infections: HAS1 ACTIVATION BY EPSTEIN-BARR VIRUS AND SYNTHETIC DOUBLE- AND SINGLE-STRANDED VIRAL RNA ANALOGS
J. Biol. Chem.,
June 13, 2008;
283(24):
16781 - 16789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias
Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13
J. Immunol.,
November 15, 2007;
179(10):
7030 - 7041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Sacre, E. Andreakos, S. Kiriakidis, P. Amjadi, A. Lundberg, G. Giddins, M. Feldmann, F. Brennan, and B. M. Foxwell
The Toll-Like Receptor Adaptor Proteins MyD88 and Mal/TIRAP Contribute to the Inflammatory and Destructive Processes in a Human Model of Rheumatoid Arthritis
Am. J. Pathol.,
February 1, 2007;
170(2):
518 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja
Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling
Am. J. Pathol.,
December 1, 2006;
169(6):
1965 - 1975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Stuhlmeier and C. Pollaschek
Adenovirus-mediated Gene Transfer of Mutated I{kappa}B Kinase and I{kappa}B{alpha} Reveal NF-{kappa}B-dependent as Well as NF-{kappa}B-independent Pathways of HAS1 Activation
J. Biol. Chem.,
December 30, 2005;
280(52):
42766 - 42773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. McCarty and K. I. Block
Multifocal Angiostatic Therapy: An Update
Integr Cancer Ther,
December 1, 2005;
4(4):
301 - 314.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yu, A. H. Rux, P. Ma, K. Bdeir, and B. S. Sachais
Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-{kappa}B-dependent manner
Blood,
May 1, 2005;
105(9):
3545 - 3551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Patel, A. D. Leal, and D. H. Gorski
The Homeobox Gene Gax Inhibits Angiogenesis through Inhibition of Nuclear Factor-{kappa}B-Dependent Endothelial Cell Gene Expression
Cancer Res.,
February 15, 2005;
65(4):
1414 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Sacre, E. Andreakos, M. Feldmann, and B. M. Foxwell
Endotoxin signaling in human macrophages: signaling via an alternate mechanism
Innate Immunity,
December 1, 2004;
10(6):
445 - 452.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Sands, A. F. Martin, E. W. Strong, and T. M. Palmer
Specific Inhibition of Nuclear Factor-{kappa}B-Dependent Inflammatory Responses by Cell Type-Specific Mechanisms upon A2A Adenosine Receptor Gene Transfer
Mol. Pharmacol.,
November 1, 2004;
66(5):
1147 - 1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Caposio, M. Dreano, G. Garotta, G. Gribaudo, and S. Landolfo
Human Cytomegalovirus Stimulates Cellular IKK2 Activity and Requires the Enzyme for Productive Replication
J. Virol.,
March 15, 2004;
78(6):
3190 - 3195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Andreakos, S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell
Distinct pathways of LPS-induced NF-{kappa}B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP
Blood,
March 15, 2004;
103(6):
2229 - 2237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Monaco and E. Paleolog
Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis
Cardiovasc Res,
March 1, 2004;
61(4):
671 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Donadelli, C. Zanchi, M. Morigi, S. Buelli, C. Batani, S. Tomasoni, D. Corna, D. Rottoli, A. Benigni, M. Abbate, et al.
Protein Overload Induces Fractalkine Upregulation in Proximal Tubular Cells through Nuclear Factor {kappa}B- and p38 Mitogen-Activated Protein Kinase-Dependent Pathways
J. Am. Soc. Nephrol.,
October 1, 2003;
14(10):
2436 - 2446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Aird
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Blood,
May 15, 2003;
101(10):
3765 - 3777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog
VEGF expression in human macrophages is NF-{kappa}B-dependent: studies using adenoviruses expressing the endogenous NF-{kappa}B inhibitor I{kappa}B{alpha} and a kinase-defective form of the I{kappa}B kinase 2
J. Cell Sci.,
February 15, 2003;
116(4):
665 - 674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Andreakos, C. Smith, C. Monaco, F. M. Brennan, B. M. Foxwell, and M. Feldmann
Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction
Blood,
February 1, 2003;
101(3):
983 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Feldmann, E Andreakos, C Smith, J Bondeson, S Yoshimura, S Kiriakidis, C Monaco, C Gasparini, S Sacre, A Lundberg, et al.
Is NF-{kappa}B a useful therapeutic target in rheumatoid arthritis?
Ann Rheum Dis,
November 1, 2002;
61(90002):
ii13 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-w. Jeong, M.-H. Yoo, T. S. Kim, J.-H. Kim, and I. Y. Kim
Protection of Mice from Allergen-induced Asthma by Selenite. PREVENTION OF EOSINOPHIL INFILTRATION BY INHIBITION OF NF-kappa B ACTIVATION
J. Biol. Chem.,
May 10, 2002;
277(20):
17871 - 17876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Napoleone, A. Di Santo, A. Bastone, G. Peri, A. Mantovani, G. de Gaetano, M. B. Donati, and R. Lorenzet
Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells: A Novel Link Between Vascular Inflammation and Clotting Activation
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2002;
22(5):
782 - 787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. CONRON, E. ANDREAKOS, P. PANTELIDIS, C. SMITH, H. L. C. BEYNON, R. M. DUBOIS, and B. M. J. FOXWELL
Nuclear Factor-kappa B Activation in Alveolar Macrophages Requires Ikappa B kinase-beta , but Not Nuclear Factor-kappa B Inducing Kinase
Am. J. Respir. Crit. Care Med.,
April 1, 2002;
165(7):
996 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Birbach, P. Gold, B. R. Binder, E. Hofer, R. de Martin, and J. A. Schmid
Signaling Molecules of the NF-kappa B Pathway Shuttle Constitutively between Cytoplasm and Nucleus
J. Biol. Chem.,
March 22, 2002;
277(13):
10842 - 10851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Paparella, T.M. Yau, and E. Young
Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update
Eur. J. Cardiothorac. Surg.,
February 1, 2002;
21(2):
232 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Denk, M. Goebeler, S. Schmid, I. Berberich, O. Ritz, D. Lindemann, S. Ludwig, and T. Wirth
Activation of NF-kappa B via the Ikappa B Kinase Complex Is Both Essential and Sufficient for Proinflammatory Gene Expression in Primary Endothelial Cells
J. Biol. Chem.,
July 20, 2001;
276(30):
28451 - 28458.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|